Full text
PDFPage 292
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Arieff A. I. Management of hyponatraemia. BMJ. 1993 Jul 31;307(6899):305–308. doi: 10.1136/bmj.307.6899.305. [DOI] [PMC free article] [PubMed] [Google Scholar]
- DeFronzo R. A., Colvin O. M., Braine H., Robertson G. L., Davis P. J. Proceedings: Cyclophosphamide and the kidney. Cancer. 1974 Feb;33(2):483–491. doi: 10.1002/1097-0142(197402)33:2<483::aid-cncr2820330224>3.0.co;2-p. [DOI] [PubMed] [Google Scholar]
- Harlow P. J., DeClerck Y. A., Shore N. A., Ortega J. A., Carranza A., Heuser E. A fatal case of inappropriate ADH secretion induced by cyclophosphamide therapy. Cancer. 1979 Sep;44(3):896–898. doi: 10.1002/1097-0142(197909)44:3<896::aid-cncr2820440316>3.0.co;2-9. [DOI] [PubMed] [Google Scholar]
- Webberley M. J., Murray J. A. Life-threatening acute hyponatraemia induced by low dose cyclophosphamide and indomethacin. Postgrad Med J. 1989 Dec;65(770):950–952. doi: 10.1136/pgmj.65.770.950. [DOI] [PMC free article] [PubMed] [Google Scholar]